Human LARP4B/KIAA0217/LARP5 ORF/cDNA clone-Lentivirus plasmid (NM_015155)

Cat. No.: pGMLP003259
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days

Pre-made Human LARP4B/KIAA0217/LARP5 Lentiviral expression plasmid for LARP4B lentivirus packaging, LARP4B lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.

Our GM-Lentiviral vector is seamlessly integrated with the GM lentivirus packaging system. Discover more about the GM lentivirus packaging system.

pdf Datasheet
pdf MSDS
pdf Terms of Use
Target products collection

Go to LARP4B/KIAA0217 products collection>>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

Purchase
Total Price: $1053.78
Shipping fee: Limited-time free
For payment issues, contact us.


Product Description

Catalog ID pGMLP003259
Gene Name LARP4B
Accession Number NM_015155
Gene ID 23185
Species Human
Product Type Lentivirus plasmid (overexpression)
Insert Length 2217 bp
Gene Alias KIAA0217,LARP5
Fluorescent Reporter ZsGreen
Mammalian Cell Selection Puromyocin
Fusion Tag 3xflag (C-Terminal)
Promoter CMV
Resistance Amplicin
ORF Nucleotide Sequence ATGACTTCTGATCAGGACGCTAAGGTTGTGGCTGAACCGCAGACGCAGAGAGTCCAGGAGGGCAAGGACAGCGCTCATCTGATGAATGGTCCTATATCTCAAACCACTTCTCAGACAAGTTCCATCCCACCTTTGAGTCAGGTACCAGCAACTAAGGTTTCAGAGCTGAACCCTAATGCAGAAGTGTGGGGGGCTCCTGTGTTACATCTGGAAGCAAGCAGTGCTGCTGACGGTGTGAGTGCTGCATGGGAGGAGGTGGCTGGCCACCACGCAGACCGTGGCCCGCAGGGATCGGATGCCAATGGTGATGGTGACCAGGGCCATGAGAATGCCGCATTGCCAGACCCGCAGGAGTCGGACCCAGCAGACATGAACGCTCTCGCTCTGGGTCCCTCAGAATATGACTCTCTGCCTGAAAATAGCGAGACAGGAGGAAATGAGTCTCAACCAGACAGCCAGGAAGACCCCCGAGAAGTACTTAAAAAAACATTGGAATTCTGCTTATCTAGGGAGAACCTTGCTAGTGACATGTATCTTATATCACAGATGGATAGTGACCAGTATGTGCCAATCACAACGGTGGCTAACCTCGACCACATCAAGAAGCTCAGCACTGATGTGGACTTGATTGTGGAAGTGCTAAGATCTTTACCTTTAGTCCAAGTGGATGAAAAGGGAGAAAAAGTAAGGCCAAATCAAAATCGCTGCATAGTAATATTGCGTGAAATATCTGAATCTACCCCCGTGGAAGAAGTAGAAGCACTATTTAAAGGAGATAATTTACCAAAATTTATAAACTGTGAATTTGCATATAATGATAATTGGTTTATTACATTTGAAACAGAAGCTGATGCACAACAGGCTTACAAATACCTTCGAGAAGAAGTCAAAACTTTTCAAGGAAAACCAATTAAGGCACGGATAAAAGCAAAGGCAATAGCTATAAACACATTTTTGCCAAAGAATGGATTTAGACCCCTGGACGTGAGCCTGTATGCCCAGCAGCGCTACGCGACGTCGTTCTACTTCCCTCCCATGTACAGCCCCCAGCAGCAGTTCCCCCTGTACAGCCTGATCACTCCCCAGACGTGGTCAGCAACGCACAGCTATCTTGACCCACCCTTGGTAACTCCATTTCCAAATACTGGATTTATAAATGGGTTTACGTCTCCAGCGTTCAAGCCTGCGGCGTCTCCTCTGACTTCTCTCAGACAGTATCCTCCTCGAAGCAGGAATCCTAGTAAATCTCATCTGCGGCATGCGATTCCTAGTGCAGAGAGGGGACCTGGGTTATTAGAAAGTCCTTCAATATTTAACTTCACTGCAGATCGATTAATTAATGGTGTCCGGAGTCCACAAACAAGGCAAGCAGGTCAAACTAGAACACGGATTCAAAACCCTTCAGCATATGCCAAGAGAGAGGCTGGGCCTGGGCGTGTGGAGCCAGGCAGTCTCGAATCCTCTCCTGGTTTAGGGAGGGGAAGGAAGAATTCCTTTGGCTACCGGAAGAAAAGGGAGGAGAAGTTTACAAGCAGCCAGACACAGTCTCCAACGCCACCAAAGCCTCCGTCGCCAAGCTTCGAGCTGGGGCTGTCCAGCTTCCCTCCATTACCTGGAGCTGCCGGCAATTTGAAGACAGAGGACTTGTTTGAAAACAGGCTATCTAGCTTGATAATAGGACCATCCAAAGAAAGGACCCTCAGTGCAGACGCAAGCGTGAACACCCTTCCTGTAGTGGTCTCCAGAGAGCCCTCGGTGCCGGCTTCTTGTGCTGTATCAGCAACGTACGAGCGATCCCCCTCCCCAGCTCATTTACCCGATGATCCCAAGGTGGCGGAGAAACAGAGGGAAACCCACAGTGTGGACAGACTTCCTTCCGCCCTCACTGCGACCGCGTGTAAATCGGTGCAGGTGAACGGAGCCGCCACGGAATTGCGAAAGCCCAGCTACGCAGAGATTTGTCAGAGAACGAGTAAAGAGCCTCCTTCTTCCCCATTGCAACCCCAAAAAGAACAAAAGCCAAACACTGTTGGTTGTGGGAAGGAGGAAAAGAAGCTGGCAGAGCCCGCAGAGAGATACCGGGAGCCCCCAGCCCTCAAGTCCACACCTGGAGCCCCCAGAGACCAGAGGCGGCCGGCGGGGGGCCGGCCCTCGCCCTCGGCCATGGGGAAGCGTCTCAGCCGAGAGCAGAGCACTCCCCCCAAGTCTCCTCAGTGA
ORF Protein Sequence MTSDQDAKVVAEPQTQRVQEGKDSAHLMNGPISQTTSQTSSIPPLSQVPATKVSELNPNAEVWGAPVLHLEASSAADGVSAAWEEVAGHHADRGPQGSDANGDGDQGHENAALPDPQESDPADMNALALGPSEYDSLPENSETGGNESQPDSQEDPREVLKKTLEFCLSRENLASDMYLISQMDSDQYVPITTVANLDHIKKLSTDVDLIVEVLRSLPLVQVDEKGEKVRPNQNRCIVILREISESTPVEEVEALFKGDNLPKFINCEFAYNDNWFITFETEADAQQAYKYLREEVKTFQGKPIKARIKAKAIAINTFLPKNGFRPLDVSLYAQQRYATSFYFPPMYSPQQQFPLYSLITPQTWSATHSYLDPPLVTPFPNTGFINGFTSPAFKPAASPLTSLRQYPPRSRNPSKSHLRHAIPSAERGPGLLESPSIFNFTADRLINGVRSPQTRQAGQTRTRIQNPSAYAKREAGPGRVEPGSLESSPGLGRGRKNSFGYRKKREEKFTSSQTQSPTPPKPPSPSFELGLSSFPPLPGAAGNLKTEDLFENRLSSLIIGPSKERTLSADASVNTLPVVVSREPSVPASCAVSATYERSPSPAHLPDDPKVAEKQRETHSVDRLPSALTATACKSVQVNGAATELRKPSYAEICQRTSKEPPSSPLQPQKEQKPNTVGCGKEEKKLAEPAERYREPPALKSTPGAPRDQRRPAGGRPSPSAMGKRLSREQSTPPKSPQ

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    Category Cat No. Products Name
    Target Antibody GM-Tg-g-IP1069-Ab Anti-LARP4B monoclonal antibody
    Target Antigen GM-Tg-g-IP1069-Ag LARP4B protein
    ORF Viral Vector pGMLP003259 Human LARP4B Lentivirus plasmid
    ORF Viral Vector vGMLP003259 Human LARP4B Lentivirus particle


    Target information

    Target ID GM-IP1069
    Target Name LARP4B
    Gene ID 23185, 217980, 721993, 307070, 101095267, 478022, 505723, 100057616
    Gene Symbol and Synonyms A630096F19,D13Wsu64e,KIAA0217,LARP4B,LARP5,RGD1310713
    Uniprot Accession Q92615
    Uniprot Entry Name LAR4B_HUMAN
    Protein Sub-location Introcelluar Protein
    Category Not Available
    Disease Not Available
    Gene Ensembl ENSG00000107929
    Target Classification Not Available

    This gene encodes a member of an evolutionarily conserved protein family implicated in RNA metabolism and translation. Members of this family are characterized by the presence of an La motif, which is often located adjacent to one or more RNA recognition motifs (RRM). Together, the two motifs constitute the functional region of the protein and enable its interaction with the RNA substrate. This protein family is divided into five sub-families: the genuine La proteins and four La-related protein (LARP) sub-families. The protein encoded by this gene belongs to LARP sub-family 4. It is a cytoplasmic protein that may play a stimulatory role in translation. [provided by RefSeq, Oct 2012]



    About GMVC

    GDU

    GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.